These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22021669)

  • 1. Bisphosphonates: beyond prevention of bone metastases.
    Rennert G
    J Natl Cancer Inst; 2011 Dec; 103(23):1728-9. PubMed ID: 22021669
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
    Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
    J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
    Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI
    J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: The association between statins and cancer incidence in a veterans population.
    Ravnskov U
    J Natl Cancer Inst; 2008 Jul; 100(13):972-3; author reply 973-4. PubMed ID: 18577750
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The association between statins and cancer incidence in a veterans population.
    Platz EA
    J Natl Cancer Inst; 2008 Jul; 100(13):972; author reply 973-4. PubMed ID: 18577751
    [No Abstract]   [Full Text] [Related]  

  • 6. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
    Skoglund B
    Acta Orthop Suppl; 2007 Dec; 78(328):3-22. PubMed ID: 18283564
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins, breast cancer, and an invisible switch?
    Byers T
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1026-7. PubMed ID: 18463398
    [No Abstract]   [Full Text] [Related]  

  • 9. The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ..
    Gnant M; Eidtmann H
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S2-6. PubMed ID: 20427029
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R; Olson K; Van Poznak C
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antimyeloma effects of zoledronate and simvastatin.
    Schmidmaier R; Simsek M; Baumann P; Emmerich B; Meinhardt G
    Anticancer Drugs; 2006 Jul; 17(6):621-9. PubMed ID: 16917207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and breast cancer prognosis: evidence and opportunities.
    Ahern TP; Lash TL; Damkier P; Christiansen PM; Cronin-Fenton DP
    Lancet Oncol; 2014 Sep; 15(10):e461-8. PubMed ID: 25186049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and breast cancer incidence and recurrence.
    Chlebowski RT; Col N
    Breast Dis; 2011; 33(2):93-101. PubMed ID: 22142660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors and bisphosphonates reduce deaths from breast cancer, studies show.
    Kmietowicz Z
    BMJ; 2015 Jul; 351():h4036. PubMed ID: 26209688
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates: prevention of bone metastases in breast cancer.
    Gnant M; Dubsky P; Hadji P
    Recent Results Cancer Res; 2012; 192():65-91. PubMed ID: 22307370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumour effects of bisphosphonates in breast cancer].
    van de Ven S; Kroep JR; Hamdy NA; Sleeboom HP; Nortier HW
    Ned Tijdschr Geneeskd; 2010; 154():A1951. PubMed ID: 21083955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant bisphosphonates for early-stage breast cancer.
    Brufsky A
    Lancet Oncol; 2011 Jul; 12(7):610-1. PubMed ID: 21708345
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging role for bisphosphonates in cancer management.
    Chlebowski RT
    Breast Dis; 2011; 33(2):55-7. PubMed ID: 22142659
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion.
    Eiermann W
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S16-7. PubMed ID: 20427028
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.